MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Gut microbiota and nutritional profiles of Parkinson’s disease patients.

    M. Lubomski, X. Xu, A. Holmes, S. Mueller, J. Yang, C. Sue, R. Davis (St Leonards, Australia)

    Objective: We investigated the gut microbiome (GM) composition in association with various clinical features and nutritional data in a large cross-sectional Australian Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Whole-transcriptome analysis of monocyte-derived macrophages from patients with Parkinson’s disease associated with mutations in the GBA gene

    T. Usenko, A. Panteleeva, K. Basharova, M. Nikolaev, A. Kopytova, A. Bezrukova, K. Senkevich, I. Miliukhina, E. Zakharova, S. Pchelina (Gatchina, Russian Federation)

    Objective: To understand specific molecular features of Parkinson’s disease associated with mutations in the GBA gene (GBA-PD), we analyzed the gene expression profile of peripheral-blood…
  • MDS Virtual Congress 2021

    DO FREEZING OF GAIT AND GAIT AUTOMATICITY IN PARKINSON’S DISEASE SHARE THE SIMILAR NEURAL SUBSTRATE?

    F. de Almeida, C. Ugrinowitsch, M. Nucci, D. Coelho, A. Moreira-Neto, E. Barbosa, L. Teixeira, E. Amaro JR., F. Horak, M. Mancini, C. Silva-Batista (São Paulo, Brazil)

    Objective: To verify if freezing of gait (FOG) in Parkinson’s disease (PD) and gait automaticity share a similar neural substrate. Background: FOG in PD may…
  • MDS Virtual Congress 2021

    Insulin resistance and Parkinson’s disease

    E. Hogg, H. Maghzi, P. Mcelhinney, E. Tan, T. Wu, H. Pomeroy, D. Dey, G. Pagano, M. Tagliati (Los Angeles, USA)

    Objective: To investigate peripheral insulin resistance and cerebral FDG-PET changes in Parkinson’s disease (PD). Background: Glycated hemoglobin levels (HbA1c) is used as a marker of…
  • MDS Virtual Congress 2021

    Sex differences in brain and cognition in de novo PD patients

    J. Oltra, C. Uribe, A. Campabadal, A. Inguanzo, G. Monté-Rubio, M. Marti, Y. Compta, F. Valldeoriola, C. Junque, B. Segura (Barcelona, Spain)

    Objective: We aimed to investigate sex differences in brain atrophy and cognition in PD de novo patients through MRI subcortical volumetry and cortical thickness (CTh).…
  • MDS Virtual Congress 2021

    Constipation in Parkinson’s disease: Clinical and Neurosonographic Study

    R. Soliman, N. Kishk, M. Oraby, A. Alsayyad, M. Abdelsalam, M. Abosrea (Cairo, Egypt)

    Objective: We aimed to study the possible impact of constipation on motor, non-motor, depressive symptoms, cognitive functions and neurosonographic findings in idiopathic Parkinson's disease (PD)…
  • MDS Virtual Congress 2021

    Neurofilament light is related to fractional anisotropy in early Parkinson’s diesease

    T. Welton, Y. Tan, S. Saffari, N. Chia, S. Ng, Z. Lu, A. Yong, X. Choi, D. Heng, YC. Shih, S. Hartono, W. Lee, Z. Xu, K. Tay, WL. Au, EK. Tan, LL. Chan, A. Ng, L. Tan (Singapore, Singapore)

    Objective: We aimed to determine whether plasma NfL reflects changes in brain white matter integrity as measured using fractional anisotropy (FA) in patients with early…
  • MDS Virtual Congress 2021

    LFP spectral features associated with therapy complications in typical and early onset Parkinson’s disease

    E. Belova, U. Semenova, A. Gamaleya, A. Tomskiy, A. Sedov (Moscow, Russian Federation)

    Objective: The aim of this study was to search for potential markers in the subthalamic nucleus activity of parkinsonian patients associated with levodopa-induced dyskinesias in…
  • MDS Virtual Congress 2021

    Evoked potentials as biomarker for deep brain stimulation programming in Parkinson’s disease

    J. Peeters, A. Boogers, T. van Bogaert, R. Gransier, J. Wouters, B. Nuttin, M. Mc Laughlin (Leuven, Belgium)

    Objective: To correlate evoked potentials (EPs) during electrical stimulation of subthalamic nucleus, to clinical outcome measures in Parkinson’s disease (PD) patients, to guide deep brain…
  • MDS Virtual Congress 2021

    Links between Cognitive Impairment and Contrast Sensitivity in Parkinson’s Disease

    C. Catiul, R. Memon, A. Memon, A. Joop, J. Pilkington, K. Wood, A. Amara (Birmingham, USA)

    Objective: To evaluate the relationship between Contrast Sensitivity (CS) and cognitive function in patients with idiopathic Parkinson’s Disease (PD) and healthy controls (HC). Background: In…
  • « Previous Page
  • 1
  • …
  • 61
  • 62
  • 63
  • 64
  • 65
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley